RxDoctor Payments Data

Johnny Abidin, MD

Internal Medicine · Lancaster, OHNPI 1902885403

Payments from drug & device makers

$1,073in general payments, 2019–2025

Across 59 payments — averaging $18.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$171
  • Abbott$156
  • Pfizer$100
  • Lilly USA, LLC$99
  • Novo Nordisk$89
  • Otsuka America Pharmaceutical, Inc.$69
  • plus $391 from 11 others

What the payments were for

  • Food & beverage$1,073100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,073 in reported general payments places this provider in the 75th percentile of 4,428 internal medicine providers in Ohio.

See all internal medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$47,811
Medicare patients
182
Services billed
813

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban110$110,008
JardianceEmpagliflozin60$69,123
OzempicSemaglutide48$55,117
XareltoRivaroxaban34$44,324
JanuviaSitagliptin Phosphate24$30,128
Tresiba Flextouch U-100Insulin Degludec12$20,038
FarxigaDapagliflozin Propanediol17$11,370
Levemir FlexpenInsulin Detemir20$6,736
MyrbetriqMirabegron11$6,643
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog11$6,453
LexaproEscitalopram Oxalate13$5,617
Lantus SolostarInsulin Glargine,hum.Rec.Anlog21$4,366
Pravastatin Sodium220$4,361
Fluticasone-SalmeterolFluticasone Propion/Salmeterol27$4,081
Rosuvastatin Calcium159$3,058

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$100$110,008110 claims
Novo NordiskOzempic$89$55,11748 claims
AstraZenecaFarxiga$55$11,37017 claims
AbbVieLexapro$171$5,61713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,428 internal medicine providers in Ohio.

Other internal medicine in Lancaster

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →